Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/1508
Full metadata record
DC FieldValueLanguage
dc.contributorO'Connor, Ellieen_US
dc.contributorAdams, Nicholasen_US
dc.contributorSiriratnum, Pakeeranen_US
dc.contributorGodfrey, Ameliaen_US
dc.contributorHu, Chih-Chiangen_US
dc.contributorLow, Ashleaen_US
dc.contributorHair, Caseyen_US
dc.contributorOqueli, Ernestoen_US
dc.contributorSharma, Ananden_US
dc.contributorKraemer, Thomasen_US
dc.contributorSahathevan, Rameshen_US
dc.date.accessioned2020-03-05T03:51:44Z-
dc.date.available2020-03-05T03:51:44Z-
dc.date.issued2019-
dc.identifier.govdoc01464en_US
dc.identifier.urihttp://hdl.handle.net/11054/1508-
dc.description.abstractBackground and Aims: Diabetes mellitus (DM) is a major risk factor for atherosclerosis-related vascular diseases. This study aimed to compare the prevalence of DM in cerebrovascular and cardiovascular disease in a regional Australian hospital. Methods: We conducted a retrospective study (January 2015 to June 2017) to determine the prevalence of DM among ischaemic stroke (IS) and acute coronary syndrome (ACS) admissions to Ballarat Health Services. Diabetic control was based on HbA1c (%), measured within three months of index presentation. Logistic regression analysis was used to determine whether statistical significance was observed. Results: We identified 470 IS and 406 ACS events. Rates of DM in both populations were similar [119 (25.3%) in IS; 122 (30.1%) in ACS; p ¼ 0.118] with type 2 DM being significantly more frequent [116 (24.7%) in IS; 115 (28.3%) in ACS; p ¼ 0.222]. Average HbA1c scores were substantially higher in IS (8.09%) than ACS (7.36%); p ¼ 0.009. There were significantly more IS patients (61.6%) with an HbA1c >7% compared with ACS (45.8%); p ¼ 0.05. Conclusions: We found no difference in the prevalence of DM in IS and ACS. This reflects the increased risk of atherosclerosis, responsible for both disease processes, in patients with DM. However, in our population, those with poorer diabetic control were more likely to develop stroke than an ischaemic cardiac event. We suggest that this might be because IS is caused by macro and microvascular disease, as opposed to ACS, which is almost exclusively a macrovascular complication of DM. Our results require validation in a larger and varied population.en_US
dc.description.provenanceSubmitted by Gemma Siemensma (gemmas@bhs.org.au) on 2020-01-15T00:47:12Z No. of bitstreams: 0en
dc.description.provenanceApproved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2020-03-05T03:51:44Z (GMT) No. of bitstreams: 1 Prevalence of diabetes ESOC 2019.pdf: 286496 bytes, checksum: d28f00217d4af8d80c5e79213fbe64f9 (MD5)en
dc.description.provenanceMade available in DSpace on 2020-03-05T03:51:44Z (GMT). No. of bitstreams: 1 Prevalence of diabetes ESOC 2019.pdf: 286496 bytes, checksum: d28f00217d4af8d80c5e79213fbe64f9 (MD5) Previous issue date: 2019en
dc.titlePrevalence of diabetes in vascular disease.en_US
dc.typeConferenceen_US
dc.type.specifiedPosteren_US
dc.bibliographicCitation.conferencedate22-24 Mayen_US
dc.bibliographicCitation.conferencename5th European Stroke Organisation Conferenceen_US
dc.bibliographicCitation.conferenceplaceMilan, Italyen_US
dc.subject.healththesaurusDIABETES MELLITUSen_US
dc.subject.healththesaurusVASCULAR DISEASEen_US
dc.subject.healththesaurusCEREBROVASCULARen_US
dc.subject.healththesaurusCARDIOVASCULARen_US
Appears in Collections:Research Output

Files in This Item:
File Description SizeFormat  
Prevalence of diabetes ESOC 2019.pdf279.78 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.